Intravenous injection chemotherapy device for hematology department nursing

Abstract

The invention discloses an intravenous injection chemotherapy device for hematology department nursing, and relates to the technical field of hematology department nursing. The intravenous injection chemotherapy device comprises a fixed box; a working box is fixedly connected to the top of the fixed box; a moving groove is formed in the working box; a temperature control groove is formed in the end, away from the moving groove, of the interior of the working box; a pressure sensor is fixedly connected to the top of the fixed box and located above the temperature control groove; a fixed plate is fixedly connected to the top end of the pressure sensor; two air boxes are fixedly connected to the interior of the fixed plate; and second fixed sleeves are fixedly connected to the tops of the airboxes. According to the intravenous injection chemotherapy device for hematology department nursing, by arranging the pressure sensor, the pressure sensor collects the weight of liquid medicine in asyringe in real time, so that a medical staff can clearly know the amount of remaining liquid medicine in the syringe and the amount of injected liquid medicine, and the amount of injected liquid medicine can be conveniently checked by family members of a patient.

Description

technical field [0001] The invention relates to the technical field of hematology nursing, in particular to an intravenous chemotherapy device for hematology nursing. Background technique [0002] Department of Hematology mainly focuses on blood-related diseases, such as: 1. Anemia (iron deficiency anemia, aplastic anemia, megaloblastic anemia, acute hemorrhagic anemia, thalassemia and hemolytic anemia), etc. 2. Leukocyte diseases (neutrophil increase and decrease, neutrophil morphology and dysfunction, eosinophilia and basophil increase or decrease, mononucleosis, granulocyte increase or decrease, immune deficiency, Myelofibrosis, myelodysplastic syndrome, leukemia, malignant lymphoma), etc. 3. Bleeding diseases (idiopathic thrombocytopenic purpura, allergic purpura, hemophilia), etc. 4. Malignant tumors of the hematopoietic system (leukemia lymphoma, malignant histiocytosis, essential thrombocythemia), etc. However, the existing medical staff cannot clearly know the amo...

AI Technical Summary

Problems solved by technology

However, the existing medical staff cannot clearly know the amount of liquid medicine remaining in the syringe and the volume of liquid medicine that has been injected. At the same time, patients are prone to local redness, swelling and blisters during intravenous chemotherapy, which makes the patient feel more uncomfortable.

Images